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 Diet in the treatment of ADHD in 
children — A systematic review of the 
literature 
 MAREN JOHANNE  HEILSKOV  RYTTER ,  LOUISE BELTOFT BORUP  ANDERSEN , 
 TINE  HOUMANN ,  NIELS  BILENBERG ,  ALLAN  HVOLBY ,  CHRISTIAN  M Ø LGAARD , 
 KIM F.  MICHAELSEN ,  LOTTE  LAURITZEN 
 Rytter MJH, Andersen LBB, Houmann T, Bilenberg N, Hvolby A, M ø lgaard C, Michaelsen 
KF, Lauritzen L. Diet in the treatment of ADHD in children — A systematic review of the 
literature. Nord J Psychiatry 2015;69:1 – 18. 
 Background: Attention-defi cit/hyperactivity disorder (ADHD) is one of the most prevalent 
psychiatric conditions in childhood. Dietary changes have been suggested as a way of reducing 
ADHD symptoms.  Aims: To provide an overview of the evidence available on dietary 
interventions in children with ADHD, a systematic review was carried out of all dietary 
intervention studies in children with ADHD.  Methods: Relevant databases were searched in 
October 2011, with an update search in March 2013. The studies included describe diet 
interventions in children with ADHD or equivalent diagnoses measuring possible changes in 
core ADHD symptoms: inattention, hyperactivity and impulsivity.  Results : A total of 52 studies 
were identifi ed, some investigating whether ADHD symptoms can improve by  avoiding certain 
food elements (20 studies), and some whether certain food elements may  reduce ADHD 
symptoms (32 studies).  Conclusion : Elimination diets and fi sh oil supplementation seem to be 
the most promising dietary interventions for a reduction in ADHD symptoms in children. 
However, the studies on both treatments have shortcomings, and more thorough investigations 
will be necessary to decide whether they are recommendable as part of ADHD treatment. 
 • ADHD ,  Dietary intervention ,  Review. 
 Maren J.H. Rytter, Department of Nutrition, Exercise and Sports, Faculty of Sciences, University 
of Copenhagen, Rolighedsvej 30, 1958 Frederiksberg, Denmark, E-mail: mryt@nexs.dk.dk; 
Accepted 2 May 2014. 
 Attention-defi cit/hyperactivity disorder (ADHD) is one of the most frequent psychiatric conditions in 
childhood. It is caused by a combination of genetic and 
environmental factors, and symptoms vary within and 
between patients. Not all children with ADHD benefi t 
from the standard pharmaceutical treatment: some expe-
rience side-effects, and there is concern about the long-
term effects of the drugs on children (1, 2). Dietary 
changes have therefore been investigated for decades as 
a way of reducing symptoms in children with ADHD (3) 
(Fig. 1). The dietary changes that have been suggested 
as potential treatments of ADHD in children fall into 
two groups: 
 1)  Dietary interventions that  remove elements from the 
diet, elimination diets; 
 2)  Dietary interventions that  increase the intake of 
certain nutrients. 
 The  removal of elements from the diet (the so-called 
elimination diets) is based on the idea that some children 
may have behavioural changes when exposed to certain 
food items. These intervention studies fall into three cat-
egories: artifi cial food colorants and other additives, 
sugar, and  “ Few Foods Diets ” . 
 The research within  artifi cial food colorants and other 
additives began in the 1970s. It was hypothesized that a 
diet without natural salicylates and artifi cial food 
colorants, the Kaiser Permanente diet, also known as the 
K-P diet or the Feingold diet, could improve symptoms 
in children with  “ hyperactivity ” or  “ minimal brain 
dysfunction ” (4). 
 A possible effect of  sugar and artifi cial sweeteners 
has been a focus among parents who report that their 
children get  “ hyperactive ” after eating a lot of sugar. A few 
observational studies have found that sugar ingestion was 
related to ADHD symptoms in children and adolescents 
© 2014 Informa Healthcare DOI: 10.3109/08039488.2014.921933
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and norepinephrine, which are involved in the symptoms 
of ADHD, are synthesized from the amino acid precur-
sors, phenylalanine, tyrosine and tryptophan (9). Thus, it 
has been suggested that supplements with these amino 
acids might help children with ADHD. In contrast, con-
cerns have been raised that intake of phenylalanine via 
the artifi cial sweetener aspartame could increase symp-
toms in children with ADHD (10). 
 The interest in  essential fatty acids in relation to 
ADHD began in 1981 (11), where the fi rst studies 
focused on supplements of n-6 fatty acids from vegetable 
oils, but the main focus in this fi eld has been the long-
chain n-3 fatty acids (n-3 LCPUFA): docosahexaenoic 
acid (DHA) and eicosapentaenoic acid (EPA) from fi sh 
oil. The n- nomenclature indicates the location of the 
double bond in the carbon chain of the fatty acid, which 
is preserved during metabolism and is essential for the 
effects. DHA has been shown to play an important role 
in the structure and function of the brain (12). Studies in 
rats have shown that defi ciencies in n-3 fatty acids, as 
well as supplementation with fi sh oil, affect levels of 
monoaminergic neurotransmitters (13). Lower blood lev-
els of DHA have been observed in children with ADHD 
as well as associations between severe ADHD symptoms 
and low DHA concentrations (14, 15). Maternal fi sh oil 
supplementation during lactation has been associated 
with offspring attention and physical activity both in ani-
mal and human studies (16, 17). 
 When it comes to  vitamins , B vitamins, especially B6 
(pyridoxine), B9 (folate) and vitamin B12 (cobalamin), 
are all involved in the synthesis of monoaminergic neu-
rotransmitters as well as in the metabolism of fatty acids 
(18). Defi ciencies may therefore have negative conse-
quences for cognitive functions. Vitamin C has also been 
used as a supplement in studies on ADHD, presumably 
based on its anti-oxidative effects, which may protect 
n-3 LCPUFA or oxidation in the brain in general, or the 
fact that it improves iron absorption. Carnitine is an 
ammonium compound with vitamin-like properties, which 
is provided by the diet or synthesized from lysine and 
methionine. Carnitine is essential for the transport of 
fatty acids. Supplementation with carnitine has been 
found to reduce ADHD-like symptoms in children with 
fragile X syndrome (19) and it has therefore been sug-
gested that it may have a benefi cial effect on children 
with ADHD. 
 The  minerals zinc, iron and magnesium have all been 
suggested as potentially relevant supplements to children 
with ADHD. Zinc is involved in the synthesis of mono-
aminergic neurotransmitters. Defi ciency in these miner-
als, specifi cally zinc and iron, is known to cause 
cognitive impairment in children (20, 21). Observational 
studies have furthermore found that children with ADHD 
have a lower status of these minerals (22 – 24). It has 
been proposed that children with ADHD may have a 
(5, 6). The question is whether this  “ hyperactivity ” is 
caused by the sugar, or by the circumstances often asso-
ciated with a high sugar intake (birthday parties, holidays 
etc.). This may be particularly relevant in the case of 
children with ADHD, who often have diffi culties in 
unstructured settings with many people. The widely used 
artifi cial sweetener aspartame has also been hypothesized 
as a problem in relation to ADHD. 
 Apart from sugar and artifi cial food colorants, it has 
been suggested that some children with ADHD could be 
sensitive to other food items, and that these specifi c food 
items vary from child to child (7). Few Foods Diets 
eliminate all but a few food items from the diet for a 
period. The diet typically consists of two types of meat, 
two sources of carbohydrates, two vegetables, two fruits, 
oil and water (8). Children are identifi ed as  “ diet sensi-
tive ” if they show improvement after a few weeks on 
this type of diet. If so, food items are re-introduced in a 
controlled way to identify any specifi c food causing the 
child to react. This can be followed by random blinded 
challenges in which the foods that the child was found 
to react to were given disguised in other foods or in 
capsules. The overall idea is to identify the food items 
to be avoided in each specifi c case and thus design an 
individual diet for future use. 
 The rational for the dietary interventions that  increase 
the intake of certain nutrients are that children with 
ADHD could have defi ciencies in these nutrients, either 
because of a low intake or because of a higher require-
ment. The nutrients in focus have been certain amino 
acids, essential fatty acids, vitamins and minerals. 
 The interest for  amino acids was raised because the 
monoaminergic neurotransmitters, dopamine, serotonin 
 Fig. 1 . Timeline: Focus of dietary interventions in relation to 
attention-defi cit/hyperactivity disorder (ADHD). The arrow 
indicates when the various dietary components fi rst became a focus 
area in ADHD research. The size of the boxes represents the 
number of studies performed within the fi eld, and the color of the 
boxes the overall type of intervention. Light grey: food elements 
hypothesized to be recommended for removal from diet in order 
to decrease ADHD symptoms, and dark grey: food elements 
hypothesized to have a benefi cial effect on ADHD symptoms when 
added to the diet. 
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 Materials and methods 
 The review was performed in accordance with a pre-
defi ned but unpublished protocol describing the aim, 
search strategy, inclusion and exclusion criteria, and the 
methods used to evaluate the studies. 
 Strategy of search and selection of literature 
 Literature search was carried out on 3 October 2011 and 
updated on 11 March 2013. The databases PubMed, Web 
of Science, PsycINFO and the Cochrane Library were 
searched for a combination of relevant words about diet 
and ADHD (Fig. 2), and the reference lists of the papers 
different metabolism of especially zinc, and also that 
zinc status could modify the effect of factors like fatty 
acids (25). Iron defi ciency has been suggested to be 
involved in restless legs syndrome (26), which shares 
some features with ADHD, and it has therefore been 
hypothesized that iron defi ciency could also play a role 
in ADHD. Moreover, iron status may also infl uence the 
metabolism of essential fatty acids (27). 
 This broad systematic review aims to assess the 
 “ state of the art ” of all the proposed dietary interven-
tions, in order to qualify recommendations and future 
research. 
1: “Food” (mesh) OR “diet” (mesh) OR “diet therapy” (mesh) OR “nutrition disorders” (mesh)
2:  “micronutrients” (mesh) OR “trace elements” (mesh) OR “zinc” (mesh) OR “Magnesium” 
(mesh) OR “magnesium deficiency” (mesh) OR “Iron” (mesh) OR “iron deficiency anemia” (mesh) 
OR “copper” (mesh) OR “calcium” (mesh) OR “Niacin” (mesh) OR “vitamin B 12” (mesh) OR 
“Dietary Supplements” (mesh) OR “vitamin D” (mesh) OR “deficiency” (mesh)
3: “Lipids” (mesh) OR “fatty acids, unsaturated” (mesh) OR “Fatty Acids, essential” (mesh) OR “Fish 
oils” (mesh) OR “fatty acids” (mesh) OR “carnitine” (mesh) 
4: “Milk, Human” (mesh) OR “Breastfeeding” (Mesh) 
5: “probiotics” (mesh) OR “candida” (mesh)  
6: “Hypersensitivity” (mesh) OR “Allergy and Immunology” (mesh) OR “immunoglobulins” (mesh),
“salicylates” (mesh) OR “Milk” (mesh) OR “Glutens” (mesh) OR “Caseins” (mesh)
7: “food additives” (mesh) OR “flavoring agents” (mesh) OR “food preservatives” (mesh) 
OR “food coloring agents” (mesh) OR “Sweetening agents” (mesh) 
8: “Dietary carbohydrates” (mesh) 
9: “Amino acids” (mesh)  
10:“Ketogenic diet” (mesh)
11: (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
12: “Attention Deficit and Disruptive Behavior Disorder” (mesh) OR “Hyperkinesis” (mesh) OR 
“Attention Deficit Disorders with Hyperreactivity” (mesh)
13: Search Limits: Clinical Trial, Meta-Analysis, Randomized Controlled Trial, Review, English, 
Danish, All Child: 0-18 years 
14: #11 AND #12 AND #13
15: Food* OR Diet* OR nutrition* OR malnutrition
16: zink* OR iron* OR magnesium* OR copper* OR Calcium* OR vitamin* OR micronutrient*
17:  “fatty acids” OR EFA OR DHA OR omega-3 OR omega-6 OR carnitine 
18: breastfeeding 
19: Probiotic* OR candida OR microbiota OR yeast
20: hyperreactivity OR allergy OR salicylates OR Feingold OR “Kaiser Permanente diet” OR “KP 
diet” OR milk OR casein OR gluten OR “oligoantgenic diet” OR “oligoallergenic diet” OR “few foods 
diet” OR “elimination diet”
21: “food additive*” OR “food colour*” OR color* OR flavour* OR preservative* 
22: sugar OR sucrose 
23:  “amino acid*”
24:  “ketogenic diet” 
25: (#15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24)
26: ADHD OR hyperactivity OR inattention OR impulsivity OR “Attention Deficit Hyperactivity 
Disorder” OR “Minimal Brain Dysfunction” 
27: Search Limits: Clinical Trial, Meta-Analysis, Randomized Controlled Trial, Review, English, 
Danish, All Child: 0-18 years 
28: #25 AND #26 AND #27
29: Search Limits: published in the last 180 days
30: #25 AND #26 AND #28
 Fig. 2 . PubMed search strategy for the main search. 
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restrictions were imposed as to whether the children 
received medication. Studies with fewer than 10 subjects 
were excluded. 
 OUTCOMES 
 Included studies should report change in core symptoms 
of ADHD (hyperactivity, impulsivity and inattention) as 
an outcome, preferably based on validated scales or tests. 
The scales used were the Conners Scales or the ADHD 
Rating Scale, but we also accepted studies using locally 
developed scales, as long as their purpose was to assess 
ADHD core symptoms. Studies that used tests to assess 
hyperactivity, impulsivity and inattention were also 
included. These comprised the Continuous Performance 
Test (CPT), Matching Familiar Figures Test, Draw-a-
Line-Slowly Test, Zero Input Tracking Analyzer and 
Auxiliary Distraction Task, Freedom from Distractibility 
Index of the Wechsler Intelligence Scale for Children, 
among others. 
 Results 
 A total of 52 studies met the inclusion criteria. The most 
frequent reasons for excluding studies were that the study 
included children not diagnosed with ADHD or similar 
conditions or did not report change in ADHD core symp-
toms, or had fewer than 10 participants. Due to the het-
erogeneous nature of the interventions, participants and 
outcomes, it was decided not to attempt to perform a 
retrieved were examined for further relevant studies. The 
literature search and selection of papers were performed 
independently by two researchers (MJHR, LBBA). 
Diverging views on inclusion of papers were discussed 
and settled between all authors of this review. Figure 3 
gives an overview of the search and selection process. 
 Inclusion criteria 
 EXPOSURE AND STUDY TYPE 
 We included literature published in English describing 
controlled/uncontrolled and blinded/open intervention 
studies, evaluating the effect of a change in diet or intake 
of a nutritional supplement on ADHD symptoms. Both 
parallel and crossover designs were allowed, and unless 
otherwise stated, the term  “ randomized controlled trial ” 
(RCT) is used to refer to the parallel studies. 
 PARTICIPANTS 
 The participants of the included studies had to be chil-
dren (0 – 18 years) with a diagnosis of ADHD or older 
diagnoses equivalent to ADHD. For recent studies, a 
diagnosis of ADHD based on  Diagnostic and Statistical 
Manual of Mental Disorders-IV (DSM-IV) or hyperki-
netic disorder based on the  International Classifi cation of 
Diseases-10 (ICD-10) was required, but older studies 
with an equivalent diagnosis, e.g.  “ minimal brain dys-
function ” , were included as well. ADHD should be the 
main diagnosis but co-morbidities were accepted. No 
PsycINFO (536)PubMed (593)
Identified interventions about diet and ADHD (103)
Excluded after reading through (51) Included after reading through (52)
Elimination diets (20)
Food colorants and
other additives (8)
Sugar and
sweeteners (5)
Few Foods Diet (7)
Food supplementation diets 
(32)
Essential fatty
acids (16)
Amino acids (3)
Minerals (7)
Vitamins (7)
Web of Science (392) Cochrane Library (47)
 Fig. 3 . Outline of studies accessed and included in the review. One study (61) is included both in the section about essential fatty acids 
and about vitamins. 
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extensive Few Foods Diets studies have found that some 
children reacted to cocoa and wheat, this may have 
blurred any possible effect of the artifi cial food colorants. 
 The ambiguous results of the studies and their meth-
odological limitations make it diffi cult to draw any fi rm 
conclusions regarding the effect of artifi cial food colo-
rants in children with ADHD. However, two large stud-
ies carried out on a general population of children (41, 
42) both found that normal children showed increase in 
ADHD-like behaviour after receiving a mix of artifi cial 
colorants, so-called  “ azo-dyes ” , together with the preser-
vative sodium benzoate. The reaction was not related to 
whether the child was known hyperactive or allergic, but 
seemed linked to genetic polymorphisms in the metabo-
lism of histamine (43). As a result, the European Union 
has passed a law stating that foods containing  “ azo-dyes ” 
should bear a warning label stating that they may have 
adverse effects on children ’ s behaviour and attention (44). 
 Four meta-analyses have been carried out on this 
issue, the most recent published in 2013 (28, 29, 45, 46). 
All conclude that artifi cial food colorants have small, but 
statistically signifi cant adverse effects on ADHD symp-
toms in some children, but that this is based on studies 
of limited quality. 
 SUGAR AND ARTIFICIAL SWEETENERS 
 Five crossover RCTs have assessed the acute effect of 
sugar and aspartame on children with ADHD or equiva-
lent diagnoses (Table 2). One of the RCTs examined 
aspartame vs. control (10), one compared sugar and 
saccharine (47), two compared sugar vs. aspartame 
(48, 49), and the last tested both sugar and aspartame vs. 
saccharine (50). Overall, these studies found no change 
in core ADHD symptoms with either sugar or aspartame; 
although one found an increase in inattention with sugar 
relative to both saccharin and aspartame (50). 
 The studies are relatively old, had few participants 
and only assessed the effect of short-term exposure. The 
studies may therefore have missed small effects, effects 
that only occurred in a minority of children, or after 
long-term exposure. Furthermore, two of the studies 
compared two food components with proposed harmful 
effects (sugar and aspartame), so it may not be possible 
to evaluate the effect of any of these compounds. At 
present, the literature does not support the theory that 
sugar, or any other sweetener, causes symptoms of 
ADHD in children. 
 FEW FOODS DIETS 
 Seven studies have attempted to test Few Foods Diets in 
children with ADHD (Table 3); only one of them, how-
ever, in a double-blinded RCT design under controlled 
conditions (51). This study was performed as a crossover 
study in hospitalized children who received all their food 
in the Few Foods Diet or a comparison diet from the 
meta-analysis, but instead report the data as a systematic 
review, where we took the size and methodological 
approach of the studies into account. Others have per-
formed meta-analyses, but heterogeneity was high 
between studies, making it questionable whether the stud-
ies were indeed suitable for pooling (28 – 31). 
 The studies fall into two groups: 1) dietary interven-
tions that  remove elements from the diet (20 studies) and 
2) dietary interventions that  increase the intake of cer-
tain nutrients (32 studies). 
 Elimination diets 
 ARTIFICIAL FOOD COLORANTS AND OTHER ADDITIVES 
 The studies assessing the effect of artifi cial food colo-
rants were either  diet studies , assessing whether ADHD 
symptoms in children improved on a diet without artifi -
cial colours (K-P diet), or  challenge studies , evaluating 
whether children ’ s symptoms worsened when exposed to 
artifi cial food colorants (Table 1). 
 Of the six studies describing the effect of the K-P 
 diet , two were uncontrolled studies (preceding challenge 
studies) (32, 33) and four had a randomized double-
blinded crossover design, in which the children followed 
a K-P diet and an equally restrictive control diet for 3 – 4 
weeks each (34 – 37). Four  challenge studies assessed the 
effect of giving artifi cial food colorants by randomized 
double-blinded crossover challenges (32, 33, 38, 39). In 
these studies, children followed a diet without artifi cial 
food colorants but were given a cookie every day, which 
on some days contained artifi cial food colorants. 
 Both uncontrolled diet studies reported improved 
symptoms after the K-P diet, whereas the results of the 
controlled studies were mixed. None of the diet RCTs 
found a signifi cant effect that was consistent among par-
ents, teachers and clinical tests, but most did fi nd an 
effect in the parent ’ s ratings. Three of the challenge 
studies found some deterioration in behaviour of the 
children when exposed to artifi cial food colorants (32, 
33, 38), whereas one study did not fi nd any effect (39). 
Many of these studies found differences in the effect 
evaluated by parents and teachers. Overall, the studies 
do not provide any clear and convincing results. 
 There are a number of limitations to the studies on 
artifi cial food colorants. First, they all had few partici-
pants: the largest included 46 children. Besides, all stud-
ies but one are more than 30 years old, so children 
included are likely to differ from the children fulfi lling 
today ’ s ADHD criteria. Some studies tested a mix of 
additives, whereas one tested only tartrazine (2 mg). It 
has, however, been suggested that the realistic daily intake 
of an American child is up to 150 mg of tartrazine (40), 
so the study may have overlooked a relevant effect. 
Finally, all the challenge studies used chocolate cookies as 
a vehicle for the food colorants. As later and more 
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hospital kitchen. Two open RCTs compared the Few 
Foods Diet with no treatment (52) or dietary instruction 
on  “ healthy food ” (53). Four uncontrolled diet studies (8, 
54 – 56) were carried out, of which all but one (54) were 
followed by double-blinded re-introduction challenges in 
the children who responded to the initial diet. 
 The double-blinded crossover RCT found a signifi cant 
improvement of ADHD symptoms with the Few Foods 
Diet, and 24% of the children were found to improve 
during the elimination diet period vs. only 4% in the 
control period (51). The two open RCTs also found 
improvement in ADHD symptoms, with response rates 
of 64 – 73% (52, 53). The four uncontrolled studies com-
paring children ’ s behaviour during the Few Foods Diet 
period with their behaviour before the introduction of the 
elimination diet also found a signifi cant decrease in 
symptoms (8, 54 – 56). In the three studies that did ran-
dom blinded challenges, the children had signifi cantly 
more ADHD symptoms when given suspected foods than 
when given control food (8, 55, 56). There was no clear 
pattern in the types of food items causing the reactions. 
 The studies of Few Foods Diets have serious limita-
tions. First, the apparent effect of the diet in the uncon-
trolled studies could be explained by factors other than 
the diet itself (e.g. the beliefs of the parents or the 
change of home-setting structure that a strict diet war-
rants). Similarly, the lack of blinding in two of the con-
trolled trials is a potential source of bias. On the other 
hand, it may be diffi cult to blind families to a diet that 
is restrictive and individually tailored to the child ’ s 
symptoms (53). Third, most studies included children of 
parents with a dietary interest (55), and only one study 
included children referred to a general child psychiatry 
clinic (51). The latter study was also the only truly 
blinded RCT, and it had the lowest proportion of 
responders. In the studies that included a double-blinded 
challenge phase, only a minority of the children com-
pleted the challenges (8, 55), either because they dropped 
out, or because the food they reacted to was not suitable 
for double-blinded challenge. The use of such a highly 
selected study groups limits the relevance of the results 
of the blinded challenges. Furthermore, a plausible bio-
logical explanation for the apparent effect of these diets 
is lacking, as this does not seem to be explainable by 
any known allergic mechanism as earlier suggested. 
 In spite of these limitations, it is intriguing that all 
seven studies found signifi cant effects on core ADHD 
symptoms. Benefi cial effects were also seen in the stud-
ies that included a double-blinded challenge, indicating 
that this might not just be a placebo effect. 
 Two recent meta-analyses have analysed the effects of 
elimination diets. One concluded that restrictive diets 
may benefi t some children with ADHD (28), the effect 
size being about one third of that of medication, and 
clinically relevant. However, this meta-analysis also 
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estimated to last around a year (53) and call for substan-
tial resources from families and the healthcare system. 
No studies followed the participants longer than 9 weeks, 
and no studies have assessed the effect of the fi nal indi-
vidual diet. Furthermore, it is not clear what specifi c 
foods the children typically react to, how restrictive the 
fi nal diets needs to be, and whether the nutritional value 
of this diet is satisfactory. 
 Increasing intake of certain nutrients 
 AMINO ACIDS 
 Three small RCTs (Table 4) have assessed potential 
effects of supplementation with amino acids (10, 58, 59). 
The results of these studies did not show any effect of 
tyrosine or phenylalanine. The study testing tryptophan 
found an improvement in ADHD symptoms on the 
parent ratings, but not in the teacher ratings (58). At 
present, there is no evidence that children with ADHD 
benefi t from amino acid supplementation, but more 
studies are needed to make fi rm conclusions. 
included studies of children who followed diets without 
food colorants, and thus did not specifi cally assess 
the effect of Few Foods Diets. The most recent meta-
analysis found that a large effect size in all included 
studies was reduced to an insignifi cant effect when look-
ing only at assessments made by an independent blinded 
assessor (29). 
 Few Foods Diets may, however, even despite a sig-
nifi cant effect, not be relevant in ordinary treatment. 
None of the studies assessed how well children accepted 
the diet. Following a diet is often described as laborious 
and disruptive to social life, and adherence is often poor 
(57). A restricted Few Foods Diet for a long period can 
become nutritionally inadequate, especially in growing 
children, and requires supervision by professionals (52). 
Few Foods Diets are not meant as treatment, but only as 
a method to identify diet-sensitive children. The actual 
treatment is the individually tailored diet designed after 
repeated challenges have identifi ed which food items 
should be avoided. The entire reintroduction process is 
 Table 2. Studies assessing the effect of sugar or aspartame on children with attention-defi cit/hyperactivity disorder (ADHD) (or 
equivalent). 
Reference Design  n , age, sex, diagnosis † Intervention Outcome measure Results (rater)
Shaywitz et  al., 
1994 (10)
RCT crossover 15, 5 – 13 years, 73% 
boys, ADD-H (d)
Aspartame (about 1.3 g * ) vs. 
control (cellulose) for 2 
weeks
Conners Scales; 
Multigrade Inventory 
scale; Matching 
Familiar Figures Test; 
Wisconsin Card 
Sorting test; the 
Children ’ s Checking 
Task and the Airplane 
test
No signifi cant difference 
on Conners Scales (P 
and T) or tests; 
Activity subscale at 
the multigrade 
Inventory (T) scale 
signifi cant lower in 
placebo group
Wender  & Solanto, 
1991 (50)
RCT crossover 
(challenge)
17, 6 – 8 years, gender 
not given, ADD-H 
(a,b)
One sugar drink (35 g) vs. 
control (aspartame or 
saccharin)
CPT Signifi cantly increased 
inattention in test after 
sugar intake; No 
signifi cant difference 
between the two 
controls
Milich  & Pelham, 
1986 (49)
RCT crossover 
(challenge)
16, 6 – 9 years, 100% 
boys, ADD-H (a,b)
One sugar drink (about 50 
mg) vs. control 
(aspartame)
Conners Scales; Tests 
developed for occasion
No signifi cant difference 
on Conners Scales (T) 
or tests
Wolraich et  al., 
1985 (48)
RCT crossover 
(challenge)
2    16, 7 – 12 years, 
100% boys, 
hyperactive (a,b)
One sugar drink (about 61 
mg * ) vs. control 
(aspartame) both fasting 
and post-prandial
Undefi ned scales; CPT; 
Draw a Line Fast test; 
Draw a Line Slowly 
test; Match Familiar 
Figures test; Paired-
associate Learning test; 
Accelerometer output
No signifi cant difference 
on scales (O), tests or 
accelerometer output, 
irrespective of fasting 
or not
Gross, 1984 (47) RCT crossover 
(challenge)
50, 5 – 7 years, 72% 
boys, hyperkinetic 
syndrome (d)
One sugar drink (75 g) vs. 
control (saccharin)
Scale made for the 
occasion rating 
behaviour
No signifi cant 
difference (P)
 RCT, randomized controlled trial; P, parents; T, teachers; O, observer; ADD-H, attention defi cit disorder with hyperactivity; CPT, 
Continuous Performance Test. 
 * Dose calculated based on child ’ s weight. 
 † Diagnosis based on: a    clinical examination, b    questionnaire, c    screening of non-diagnosed population for new cases followed by 
clinical examination, d    not given. 
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 Overall, the plant oil interventions did not fi nd any 
convincing benefi cial effects on ADHD symptoms. One 
uncontrolled study supplementing with 400 mg/day of 
ALA for 3 months found a reduction in total hyperactiv-
ity score on parent rating scales, relative to before the 
intervention (74). However, a RCT (75) found no effect 
after 7 weeks of supplementation with 120 mg/day of 
ALA and 480 mg/day of LA. Only one small study (73) 
examined the effect of exclusive supplementation with 
n-6 fatty acids and did not fi nd any effect. 
 ESSENTIAL FATTY ACIDS 
 We identifi ed 16 studies investigating the effect of essen-
tial fatty acids supplementation on ADHD symptoms in 
children. Thirteen of these studies supplemented with fi sh 
oils containing n-3 LCPUFA (DHA and EPA) (60 – 72). 
Three studies used plant oil supplements providing lino-
leic acid (LA) and alpha-linolenic acid (ALA) (73 – 75) 
(Table 5). Six of the studies giving fi sh oil also supple-
mented with n-6 fatty acids, usually gamma-linolenic 
acid (GLA). 
 Table 3. Studies assessing Few Foods Diets in children with attention-defi cit/hyperactivity disorder (ADHD). 
Reference Design  n , age, sex, diagnosis † Intervention Outcome measure Results (rater)
Pelsser et  al., 
2011 (53)
Open RCT 100, 4 – 8 years, 86% 
boys, ADHD (a)
5-week elimination 
diet vs. instructions 
on healthy diet
Conners and the 
ADHD rating 
scales
Signifi cantly fewer symptoms 
with elimination diet on 
Conners and the ADHD 
rating scales (T and P); 
Improvement for 64% of 
children
Pelsser, Frankena, 
et  al., 2009 (52)
Open RCT 27, 4 – 9 years, 81% 
boys, ADHD (a)
5-week elimination 
diet vs. waiting list
Conners and the 
ADHD rating 
scales
Signifi cantly fewer symptoms 
with elimination diet on 
Conners and the ADHD 
rating scales (P and T); 
Improvement for 73% of 
children
Schmidt et  al., 
1997 (51)
RCT crossover 49, 6 – 12 years, 96% 
boys, ADHD (47 
children) and/or 
conduct disorder 41 
children) (a)
9-week elimination 
diet vs. control diet
Conners Scales; 
CPT and PALT 
tests
Signifi cantly fewer symptoms 
with elimination diet on 
Conners Scales (O, not T) 
or CPT and PALT tests; 
Improvement for 25% of 
children
Boris  & Mandel 
1994 (56)
Uncontrolled diet   blind 
crossover challenge
26, 3 – 12 years, 73% 
boys, ADHD (a)
2-week diet  → open 
challenge  → blind 
random challenge
Conners Scales Improvement with diet for 
73% of children on Conners 
Scales (P); Signifi cantly 
more symptoms with 
suspected foods in blind 
challenge
Carter et  al., 
1993 (8)
Uncontrolled diet   blind 
crossover; Challenge
78, 3 – 12 years, 88% 
boys, ADHD (a)
3-week diet  → open 
challenge  → blind 
random challenge
Conners Scales; 
PALT and 
MFF test.
Improvement with diet for 
76% of children on Conners 
Scales (P); Signifi cantly 
more symptoms with 
suspected foods (P and O) 
and improved PALT and 
MFF test. test results
Egger et  al., 
1985 (55)
Uncontrolled diet   blind 
crossover challenge
76, 2 – 15 years, gender 
not given, 
hyperkinetic syndrome 
or overactivity 
behavioural 
disturbance (a)
3-week diet  → open 
challenge  → blind 
random challenge
Conners Scales; 
Porteus maze 
test and MFF, 
accelerometer
Improvement with diet for 
82% of children (P and O); 
Signifi cantly more 
symptoms with suspected 
foods on Conners Scales (P 
and O) and Porteus maze 
test and MFF tests, but no 
change in accelerometer
Rapp, 1978 (54) Uncontrolled diet 24, 5 – 16 years, gender 
not given, hyperactive 
(a)
1-week diet  → open 
challenge
GCI Improvement on diet for 50% 
of children on GCI (P)
 RCT, randomized controlled trial; P, parents; T, teachers; O, observer; GCI, Global Clinical Impression; PALT, Paired Associate 
Learning Test; MFF, Matching Familiar Figures Test; CPT, Continuous Performance Test; GCI, Global Clinical Impression. 
 † Diagnosis based on: a    clinical examination, b    questionnaire, c    screening of non-diagnosed population for new cases followed by 
clinical examination, d    not given. 
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duration from 4 to 26 weeks, and six of the studies 
lasted    15 weeks (60 – 62, 68 – 70, 72). Assuming that 
fi sh oil affects ADHD symptoms by incorporation into 
the brain, it may be expected to take some time before 
any effect occurs. The study showing an effect on over-
all ADHD-scale scores (72) and one of the studies with 
subscale effects (68) were among the four studies 
that had    90 participants, gave    500 mg/day of n-3 
LCPUFA and lasted    15 weeks. 
 Most of the fi sh oil RCTs used plant oil as control 
(63, 65 – 68, 70, 72), and as mentioned above these oils 
have been used as the primary intervention in other stud-
ies (73 – 75). This seems contradictory, but as the plant 
oils are used in low doses and furthermore have not 
been shown to affect ADHD symptoms, this is not 
expected to blur the possible effect of fi sh oil. One study 
have used fi sh oil supplementation in combination with 
other fatty acids, vitamins and minerals (61) and caution 
should be taken to interpret these results together with 
the studies only intervening with fi sh oil. Three studies 
allowed participant to be on ADHD medication (62, 63) 
or gave fi sh oil as an adjunction to medication (60). 
 Overall, the evidence for a reduction in ADHD symp-
toms following supplementation with essential fatty acids 
from plant oils is sparse and showed no clear improve-
ments in ADHD symptoms. Biologically, it is more 
plausible that supplementation with n-3 LCPUFA could 
 In the fi sh oil supplementation trials, one of the two 
uncontrolled studies found a reduction in ADHD symp-
toms (64). However, the results from the 11 controlled 
RCTs are more ambiguous. One of the RCTs reported a 
signifi cant difference in an overall ADHD symptom scale 
between the intervention and the control group (72), 
while the remaining 10 studies did not fi nd any overall 
effect. However, three of them (62, 68, 69) did fi nd a 
positive effect on one or more of the ADHD subscales, 
although not on the same subscales in all studies, and 
one (65) found a positive effect on the CPT. 
 The fi sh oil RCTs have four major limitations: fre-
quent use of multiple testing, a relatively low number of 
participants, low doses of n-3 LCPUFA, and relatively 
short intervention periods. Multiple testing using many 
evaluation scales is seen because n-3 LCPUFA may 
affect ADHD symptom areas differently, but without 
correction for multiple testing it increases the risk of 
chance fi ndings. Only four of the fi sh oil RCTs had    90 
participants (68 – 70, 72) and detecting a possible effect 
of fi sh oil on ADHD symptoms may require the power 
of an even larger number of participants. Most of the 
studies have used lower doses than those generally used 
in fi sh oil research (typically 1 – 3 g/day of n-3 LCPUFA) 
(76). Only two of the RCTs gave    1 g/day of n-3 
LCPUFA (66, 70), and fi ve gave 0.5 – 1 g/day of n-3 
LCPUFA (62, 63, 67, 68, 72). The interventions had a 
 Table 4. Studies assessing the effect of amino acids on children with attention-defi cit/hyperactivity disorder (ADHD) (or equivalent). 
Reference Design N, age, sex, diagnosis † Intervention Outcome measure Results (rater)
Shaywitz et  al., 
1994 (10)
RCT crossover 15, 5 – 13 years, 73% 
boys, ADD (a)
Phenylalanine (as 
aspartame) 300 mg 
vs. control (cellulose) 
for 2 weeks
Conners and Multigrade 
Inventory scales; 
Matching Familiar 
Figurs Test, Wisconsin 
Card Sorting test, the 
Children ’ s Checking 
Task and the Airplane 
tests
No signifi cant difference on 
Conners and multigrade 
Inventory scales (P or T) or the 
Matching Familiar Figures Test, 
Wisconsin Card Sorting test, the 
Children ’ s Checking Task and 
the Airplane tests
Zametkin et  al., 
1987 (59)
RCT crossover 11, 6 – 12 years, 100% 
boys, ADD-H (a)
Phenylalanine, 400 – 700 
mg  *  vs. control 
tablets for 2 weeks
Conners Scales; CGI, CPT No signifi cant difference on 
Conners Scales (P) or CGI and 
CPT tests
Nemzer et  al., 
1986 (58)
RCT crossover 14, 7 – 12 years, 79% 
boys, ADD (a,b)
Tyrosine, 4.2 g or 
tryptophan, 3 g  *  vs. 
control (lactose) each 
for 1 week
Conners Scales and, 
David ’ s Hyperkinetic 
Scale; WISC-R
No signifi cant difference on 
Conners Scales and, David ’ s 
Hyperkinetic Scale with 
tyrosine (P and T) or WISC-R 
Subtest of Concentration and 
Impulsivity; Signifi cant 
improvement on Conners Scales 
and, David ’ s Hyperkinetic Scale 
with tryptophan (P, not T), but 
not in test
 RCT, randomized controlled trial; P, parents; T, teachers; O, observer; ADD-H, attention defi cit disorder; ADD-H, attention defi cit 
disorder with hyperactivity, Swanson, Nolan and Pelham rating; CPT, Continuous Performance Test; CGI, Clinical Global Impression 
scale; WISC-R, Wechsler Intelligence Scale for Children — Revised. 
 * Dose calculated based on child ’ s weight. 
 † Diagnosis based on: a    clinical examination, b    questionnaire, c    screening of non-diagnosed population for new cases followed by 
clinical examination, d    not given. 
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By contrast, a Cochrane review concluded that there is 
little evidence that LCPUFA supplementation provides 
any benefi t for the symptoms of ADHD in children and 
adolescents (31). A fourth meta-analysis calculated that, 
to show an effect, a study needs 330 participants and 
none of the current studies can match this (30). 
 VITAMINS 
 Seven studies (Table 6) investigated whether children 
with ADHD could benefi t from vitamin supplementation. 
However, none of these studies investigated the use of 
multi-vitamin supplements in doses in line with the 
Recommended Daily Allowances (RDA), but all supplied 
decrease ADHD symptoms. Despite a number of rela-
tively new and large intervention studies on this topic, 
there is still no fi rm evidence for the effect, and only 
one study found an overall effect. 
 The most recent systematic reviews and meta-analyses 
of the studies assessing the effect of LCPUFA on ADHD 
symptoms conclude that these fatty acids have a small 
(29) to modest (30) effects in the treatment of ADHD. 
One meta-analysis (30) found the effect to be mediated 
by n-3 LCPUFA, while another combined studies with 
n-3 and n-6 LCPUFA, and found that the small but sig-
nifi cant effects remained even after excluding studies 
with simultaneously medication from the analysis (29). 
 Table 6. Studies assessing the effect of vitamins on children with attention-defi cit/hyperactivity disorder (ADHD) (or equivalent). 
Reference Design  n , age, sex, diagnosis † Intervention Outcome measure Results (rater)
Abbasi et  al., 2011 (82) RCT 40, 7 – 13 years, 70% 
boys, ADHD (a)
Acetyl-L-carnitine, 1 – 3 g 
vs. methylphenidate for 
6 weeks
ADHD rating scales No signifi cant difference 
on ADHD rating scales 
(P and T), but possibly 
fewer side-effects of 
methylphenidate
Arnold et  al., 2007 (81) RCT 112, 5 – 12 years, 74% 
boys, ADHD (a)
Acetyl-L-carnitine, 1 – 3 g 
vs.  “ identical soluble 
powder ” for 16 weeks
Conners and CGI 
scales
No signifi cant difference 
on Conners and CGI 
scales (P and T)
Harding et  al., 2003 (61) Open uncontrolled 20, 7 – 12 years, 
gender not given, 
ADHD (a)
Mix of various mega-
doses vitamins   fi sh 
oil, amino acids, 
probiotics vs. 
methylphenidate 
(duration not given)
CPT No signifi cant difference 
between treatments on 
CPT tests
Van Oudheusden  & 
Scholte, 2002 (80)
RCT crossover 26, 6 – 13 years, 100% 
boys, ADHD (a)
L-Carnitine, 3 g a vs. 
identically looking and 
tasting drink for 8    3 
weeks
Conners and CBCL 
scales
Signifi cant improvement 
on Conners and CBCL 
scales (T and P)
Haslam et  al., 1984 (79) Uncontrolled   RCT 
crossover
41 (7 in RCT), 7 – 11 
years, both boys 
and girls (gender-
ratio not given), 
ADD (a,b)
3-month open-phase with 
increasing doses of 
vitamin for all 
Followed by RCT with 
mega-doses vit. B3, B5, 
B6 and C vs. placebo 
capsule for 6 weeks.
Conners Scale No signifi cant difference 
on Conners Scales 
(P, T and O)
Brenner, 1982 (78) RCT crossover 100, 4 – 15 years, 
gender not given, 
MBD (a)
Mega-dose vit. B1, B5, 
B6 or control (lactose) 
for 3 days each
No scales used Tendency towards 
improvement on days 
with one of the 
vitamins (mostly to vit. 
B5) (no statistical 
testing)
Arnold et  al., 1978 (77) RCT 31, 5 – 12 years, 74% 
boys, MBD (a,b)
Mega-dose vit. B3, B5, 
B6, C and glutamate 
vs. similar tasting 
placebo powder for 2 
weeks
Conners Scales and 
David ’ s 
Hyperkinetic 
Rating Scale
No signifi cant difference 
on Conners Scales and 
David ’ s Hyperkinetic 
Rating Scale, 
(P and T)
 RCT, randomized controlled trial; RDA, Recommended Daily Allowance; P, parents; T, teachers; O, observer; ADD-H, attention defi cit 
disorder with hyperactivity; MBD, minimal brain dysfunction; CPT, Continuous Performance Test; CGI, Clinical Global Impression 
scale; CBCL, Clinical Behavior Checklist. 
 † Diagnosis based on: a    clinical examination, b    questionnaire, c    screening of non-diagnosed population for new cases followed by 
clinical examination, d    not given. 
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problems, such as lack of randomization, and ADHD 
symptoms were not assessed by any known rating scale. 
 Based on these studies, there is no evidence to 
recommend zinc, iron or magnesium supplements to 
children with ADHD, but supplementation with zinc 
could be considered in areas with a high prevalence of 
zinc defi ciency. 
 Conclusion 
 For most of the interventions regarding dietary compo-
nents in children with ADHD, only few studies have 
been conducted, most with few participants and with a 
number of methodological fl aws. These include problems 
concerning whether the rater was truly blinded (a parent 
involved in delivering the intervention may not be truly 
blinded), and old studies with uncertainty regarding the 
diagnostic classifi cation as well as the psychometric qual-
ities of the outcome measures used. Most studies did not 
mention whether the effect of dietary treatment depended 
on age, although a few studies found that artifi cial food 
colours had a more pronounced effect in the youngest 
(pre-school) children (32, 33). Thus, for most dietary 
interventions there is not enough evidence to recommend 
their routine use in clinical practice. There is some evi-
dence that certain artifi cial food colorants may affect 
behaviour in children, but this effect is apparently not 
specifi c for children with ADHD. A few studies suggest 
that children with ADHD and sub-clinical defi ciencies of 
zinc may benefi t from supplementation. 
 Two types of interventions, Few Foods Diets and fi sh 
oil supplementation, seem to hold some promises with 
respect to reducing ADHD symptoms, but both need 
more thorough investigation before recommendations can 
be made. Few Foods Diets appear to have a consistently 
positive effect in the short-term in some children with 
ADHD. It is, however, not meant as a long-term treat-
ment, but a diagnostic tool to identify children who are 
sensitive to certain foods. It is unknown what character-
izes the types of food components that are problematic 
and few studies have assessed the effect of subsequent 
food challenges for more than a few weeks, and no stud-
ies have described the effect of the fi nal diet. Several 
properly randomized and controlled trials have investi-
gated the effect of fi sh oil supplementation, but the 
results are currently inconclusive with respect to the 
overall effi cacy on ADHD symptoms. This may be 
explained by the low doses used in the studies, short 
intervention duration and lack of power. Meta-analysis 
of the fi sh oil RCTs tend to show some evidence for a 
small to modest effect and there are plausible biological 
mechanisms. Furthermore, fi sh oil-supplementation offers 
minimal inconvenience and no major side-effects. 
 Dietary alternatives in the treatment of ADHD patients 
are welcome, as the current pharmacological treatment is 
specifi c vitamins in  “ mega-doses ” , many times above 
RDA (61, 77 – 79). One non-randomized (61) and one 
controlled study (78), which supplied mega-doses of dif-
ferent vitamins, reported an effect, but these studies have 
severe methodological limitations, such as lack of ran-
domization, extremely short intervention periods and lack 
of statistical testing. Two more well-designed RCTs test-
ing mega-doses of combinations of vitamins B3, B5, B6 
and C, did not fi nd any effect (77, 79). One of them 
reported deterioration in some ADHD symptoms after 
vitamin supplementation, and nearly half of the children 
developed elevated levels of liver enzymes when taking 
the vitamins, suggesting that the supplements may have a 
harmful effect (79). One small RCT found a positive 
effect of carnitine supplementation (80), but two larger 
RCTs did not fi nd any effect (81, 82), although one did 
suggest a benefi t to children with the inattentive subtype 
of ADHD (81). 
 Overall, there is no evidence that mega-dose vitamin 
supplementation ameliorate symptoms in children with 
ADHD. Moreover, studies indicate that megadoses of 
vitamins B3, B5, B6 and C combined may be liver toxic 
and should be discouraged. 
 MINERALS 
 We identifi ed seven studies (Table 7) investigating the 
effect of mineral supplementation in children with 
ADHD: three RCTs focusing on zinc (83 – 85), two on 
iron (86, 87), and two on magnesium (88, 89). Two of 
the three double-blind RCTs of the effect of zinc supple-
mentation found a signifi cant positive effect on ADHD 
symptoms (83, 84), and one of them found that children 
with the lowest blood concentration of zinc and essential 
fatty acids benefi ted the most from the supplement. How-
ever, this study was limited by a high dropout rate, and 
the supplied dose of zinc (150 mg/day) was so high that 
it may have caused side-effects (84). The last study used 
a lower dose of zinc, which was increased halfway 
through the study (85). Although this did not result in 
any effect on ADHD symptoms, the group receiving zinc 
required a lower dose of central stimulating drugs (85). 
The two studies reporting an effect were carried out in 
Iran and Turkey, whereas the study that did not fi nd any 
effect was from the USA where the prevalence of zinc 
defi ciency may be lower. 
 In the studies with iron supplementation, a signifi cant 
effect was only observed in a small uncontrolled inter-
vention (86), whereas no effect on ADHD symptoms 
was found in the RCT, although a tendency towards 
improvement was found measured by Clinical Global 
Impression (87). This RCT was rather small and included 
children without anaemia, but with low iron stores 
(s-ferritin    30 mg/kg). Two studies with magnesium 
supplementation (88, 89) both reported improvement in 
ADHD symptoms, but both have severe methodological 
DIET IN THE TREATMENT OF ADHD IN CHILDREN
NORD J PSYCHIATRY·VOL 69 NO 1·2015 15
   Ta
bl
e 
7.
  S
tu
di
es
 a
ss
es
si
ng
 t
he
 e
ff
ec
t 
of
 m
in
er
al
s 
on
 c
hi
ld
re
n 
w
ith
 a
tte
nt
io
n-
de
fi c
it/
hy
pe
ra
ct
iv
ity
 d
is
or
de
r 
(A
D
H
D
) 
(o
r 
eq
ui
va
le
nt
).
  
R
ef
er
en
ce
D
es
ig
n
 n ,
 a
ge
, s
ex
, d
ia
gn
os
is
 †  
In
te
rv
en
tio
n
O
ut
co
m
e 
m
ea
su
re
R
es
ul
ts
 (
ra
te
r)
A
rn
ol
d 
et
   a
l.,
 2
01
1 
(8
5)
R
C
T
52
, 6
 – 1
4 
ye
ar
s,
 8
4%
 b
oy
s,
 
A
D
H
D
 (
a)
Z
in
c 
gl
yc
in
at
e,
 1
5 –
 30
 m
g 
vs
. c
on
tr
ol
 (
no
t 
gi
ve
n)
 
fo
r 
13
 w
ee
ks
 (
8 
w
ee
ks
 
w
ith
ou
t 
an
d 
5 
w
ee
ks
 
w
ith
 d
-a
m
ph
et
am
in
e)
C
on
ne
rs
 a
nd
 S
N
A
P-
IV
 
sc
al
es
; 
M
M
F,
 C
PT
 a
nd
 
Se
at
 A
ct
iv
ity
 t
es
ts
N
o 
si
gn
ifi 
ca
nt
 d
if
fe
re
nc
e 
on
 
C
on
ne
rs
 a
nd
 S
N
A
P-
IV
 s
ca
le
s 
(P
 a
nd
 T
) 
or
 M
M
F,
 C
PT
 a
nd
 
Se
at
 A
ct
iv
ity
 t
es
ts
K
on
of
al
 e
t  
 al
., 
20
08
 (
87
)
R
C
T
23
, 5
 – 8
 y
ea
rs
, 7
7%
 b
oy
s,
 
A
D
H
D
 (
a)
 
    N
on
-a
ne
m
ic
 
Fe
rr
iti
n  
  
    3
0 
ng
/m
l
Ir
on
, 8
0 
m
g 
vs
. i
de
nt
ic
al
 
ta
bl
et
s 
fo
r 
12
 w
ee
ks
C
on
ne
rs
 a
nd
 A
D
H
D
 r
at
in
g 
sc
al
es
; 
G
C
I
N
o 
si
gn
ifi 
ca
nt
 d
if
fe
re
nc
e 
on
 
C
on
ne
rs
 a
nd
 A
D
H
D
 r
at
in
g 
sc
al
es
 (
P 
an
d 
T
),
 b
ut
 
si
gn
ifi 
ca
nt
 e
ff
ec
t 
on
 G
C
I;
M
ou
sa
in
-B
os
c 
et
   a
l.,
 2
00
6 
(8
9)
U
nc
on
tr
ol
le
d
40
, 0
 – 1
5 
ye
ar
s,
 g
en
de
r 
no
t 
gi
ve
n 
A
D
H
D
 (
a)
M
ag
ne
si
um
, 1
80
 m
g 
    v
it.
 
B
6,
 1
8 
m
g 
fo
r 
0 –
 6 
m
on
th
s
N
o 
sc
al
es
 u
se
d
G
en
er
al
 i
m
pr
ov
em
en
t
A
kh
on
dz
ad
eh
 e
t  
 al
., 
20
04
 (
83
)
R
C
T
44
, 5
 – 1
1 
ye
ar
s,
 6
0%
 b
oy
s,
 
A
D
H
D
 (
a)
Z
in
c 
su
lp
ha
te
, 5
5 
m
g 
vs
. 
co
nt
ro
l 
(s
uc
ro
se
) 
fo
r 
6 
w
ee
ks
A
D
H
D
 r
at
in
g 
sc
al
es
Si
gn
ifi 
ca
nt
 b
en
efi
 c
ia
l 
ef
fe
ct
 o
f 
zi
nc
 o
n 
A
D
H
D
 r
at
in
g 
sc
al
es
 
(P
 a
nd
 T
)
B
ili
ci
 e
t  
 al
., 
20
04
 (
84
)
R
C
T
40
0,
 6
 – 1
4 
ye
ar
s,
 g
en
de
r 
no
t 
gi
ve
n 
A
D
H
D
 (
c)
Z
in
c 
su
lp
ha
te
, 1
50
 m
g 
vs
. 
co
nt
ro
l 
(s
uc
ro
se
) 
fo
r 
12
 w
ee
ks
C
on
ne
rs
, D
uP
au
l 
Pa
re
nt
 
R
at
in
gs
 o
f 
A
D
H
D
 a
nd
 
oc
ca
si
on
al
 d
ev
el
op
ed
 
sc
al
es
Si
gn
ifi 
ca
nt
 b
en
efi
 c
ia
l 
ef
fe
ct
 o
f 
zi
nc
 o
n 
C
on
ne
rs
, D
uP
au
l 
Pa
re
nt
 R
at
in
gs
 o
f 
A
D
H
D
 a
nd
 
oc
ca
si
on
al
 d
ev
el
op
ed
 s
ca
le
s 
(P
 
an
d 
T
)
Se
ve
r 
et
   a
l.,
 1
99
7 
(8
6)
U
nc
on
tr
ol
le
d
14
, 7
 – 1
1 
ye
ar
s,
 1
00
%
 b
oy
s,
 
A
D
H
D
 (
a)
, N
on
-i
ro
n-
de
fi c
ie
nt
Ir
on
, 1
50
 m
g  *
   f
or
 1
 m
on
th
C
on
ne
rs
 S
ca
le
s
Si
gn
ifi 
ca
nt
 i
m
pr
ov
em
en
t 
on
 
C
on
ne
rs
 S
ca
le
s 
(P
, n
ot
 T
)
St
ar
ob
ra
t-
H
er
m
el
in
  &
  
K
oz
ie
le
c,
 1
99
7 
(8
8)
O
pe
n,
 n
on
-r
an
do
m
iz
ed
 
co
nt
ro
lle
d
75
, 7
 – 1
2 
ye
ar
s,
 g
en
de
r 
no
t 
gi
ve
n,
 A
D
H
D
 (
a)
M
ag
ne
si
um
, 2
00
 m
g 
vs
. 
 “ s
ta
nd
ar
d 
tr
ea
tm
en
t ”
  f
or
 
6 
m
on
th
s
C
on
ne
rs
 S
ca
le
s 
an
d 
W
en
de
r ’ s
 
Sc
al
e 
of
 B
eh
av
io
r 
an
d 
th
e 
Q
uo
tie
nt
 o
f 
D
ev
el
op
m
en
t 
to
 F
re
ed
om
 f
ro
m
 
D
is
tr
ac
tib
ili
ty
Si
gn
ifi 
ca
nt
 e
ff
ec
t 
of
 m
ag
ne
si
um
 
on
 C
on
ne
rs
 S
ca
le
s 
an
d 
W
en
de
r ’ s
 S
ca
le
 o
f 
B
eh
av
io
r 
an
d 
th
e 
Q
uo
tie
nt
 o
f 
D
ev
el
op
m
en
t 
to
 F
re
ed
om
 
fr
om
 D
is
tr
ac
tib
ili
ty
 (
P 
an
d 
T
)
 R
C
T,
 r
an
do
m
iz
ed
 c
on
tr
ol
le
d 
tr
ia
l; 
G
C
I,
 G
lo
ba
l 
C
lin
ic
al
 I
m
pr
es
si
on
; 
P,
 p
ar
en
ts
; T
, t
ea
ch
er
s;
 O
, o
bs
er
ve
r;
 S
N
A
P-
IV
 s
ca
le
, S
w
an
so
n,
 N
ol
an
 a
nd
 P
el
ha
m
 r
at
in
g 
sc
al
e;
 M
M
F,
 M
at
ch
in
g 
Fa
m
ili
ar
 F
ig
ur
es
 T
es
t; 
C
PT
, C
on
tin
uo
us
 P
er
fo
rm
an
ce
 T
es
t.   
  *  D
os
e 
ca
lc
ul
at
ed
 b
as
ed
 o
n 
ch
ild
 ’ s
 w
ei
gh
t.   
  †  D
ia
gn
os
is
 b
as
ed
 o
n:
 a
    
    c
lin
ic
al
 e
xa
m
in
at
io
n,
 b
    
    q
ue
st
io
nn
ai
re
, c
    
    sc
re
en
in
g 
of
 n
on
-d
ia
gn
os
ed
 p
op
ul
at
io
n 
fo
r 
ne
w
 c
as
es
 f
ol
lo
w
ed
 b
y 
cl
in
ic
al
 e
xa
m
in
at
io
n,
 d
    
    n
ot
 g
iv
en
.   
M J HEILSKOV RYTTER ET AL.
16 NORD J PSYCHIATRY·VOL 69 NO 1·2015
 Shaywitz  BA ,  Sullivan  CM ,  Anderson  GM ,  Gillespie  SM ,  10. 
Sullivan  B ,  Shaywitz  SE .  Aspartame, behavior, and cognitive 
function in children with attention defi cit disorder .  Pediatrics 
 1994 ; 93 : 70 – 5 . 
 Colquhoun  I ,  Bunday  S .  A lack of essential fatty acids as a 11. 
possible cause of hyperactivity in children .  Med Hypotheses 
 1981 ; 7 : 673 – 9 . 
 Lauritzen  L ,  Hansen  HS ,  J ø rgensen  MH ,  Michaelsen  KF .  The 12. 
essentiality of long chain n-3 fatty acids in relation to development 
and function of the brain and retina .  Prog Lipid Res  2001 ;
 40 : 1 – 94 . 
 Transler  C ,  Mitchell  S ,  Eilander  A .  Could polyunsaturated fatty 13. 
acids defi ciency explain some dysfunctions found in ADHD? 
 Hypotheses from animal research. J Atten Disord  2013 ; 17 : 20 – 8 . 
 Antalis  CJ ,  Stevens  LJ ,  Campbell  M ,  Pazdro  R ,  Ericson  K , 14. 
 Burgess  JR .  Omega-3 fatty acid status in attention-defi cit/
hyperactivity disorder .  Prostaglandins Leukot Essent Fatty Acids 
 2006 ; 75 : 299 – 308 . 
 Colter  AL ,  Cutler  C ,  Meckling  KA .  Fatty acid status and 15. 
behavioural symptoms of attention defi cit hyperactivity disorder 
in adolescents: A case – control study .  Nutr J  2008 ; 7 : 8 . 
 Delgado-Noguera  MF ,  Calvache  JA ,  Bonfi ll Cosp  X .  Supplementa-16. 
tion with long chain polyunsaturated fatty acids (LCPUFA) to 
breastfeeding mothers for improving child growth and development . 
 Cochrane Database Syst Rev  2010 ;CD 007901 . 
 Asserh ø j  M ,  Nehammer  S ,  Matthiessen  J ,  Michaelsen  KF ,  Lauritzen 17. 
 L .  Maternal fi sh oil supplementation during lactation may adversely 
affect long-term blood pressure, energy intake, and physical activity 
of 7-year-old boys .  J Nutr  2009 ; 139 : 298 – 304 . 
 Kennedy  DO ,  Haskell  CF .  Vitamins and cognition: What is the 18. 
evidence?  Drugs  2011 ; 71 : 1957 – 71 . 
 Torrioli  MG ,  Vernacotola  S ,  Peruzzi  L ,  Tabolacci  E ,  Mila  M ,  19. 
Militerni  R ,  et  al .  A double-blind, parallel, multicenter comparison 
of L-acetylcarnitine with placebo on the attention defi cit 
hyperactivity disorder in fragile X syndrome boys .  Am J Med 
Genet A  2008 ; 146 : 803 – 12 . 
 Lozoff  B ,  Beard  J ,  Connor  J ,  Barbara  F ,  Georgieff  M ,  Schallert  T . 20. 
 Long-lasting neural and behavioral effects of iron defi ciency in 
infancy .  Nutr Rev  2006 ; 64 : S34 – 43 ;  discussion S72 – 91. 
 DiGirolamo  AM ,  Ramirez-Zea  M .  Role of zinc in maternal and 21. 
child mental health .  Am J Clin Nutr  2009 ; 89 : 940S – 945S . 
 Kozielec  T ,  Starobrat-Hermelin  B .  Assessment of magnesium levels 22. 
in children with attention defi cit hyperactivity disorder (ADHD) . 
 Magnes Res  1997 ; 10 : 143 – 8 . 
 Arnold  LE ,  Bozzolo  H ,  Hollway  J ,  Cook  A ,  DiSilvestro  RA , 23. 
 Bozzolo  DR ,  et  al .  Serum zinc correlates with parent- and 
teacher-rated inattention in children with attention-defi cit/
hyperactivity disorder .  J Child Adolesc Psychopharmacol 
 2005 ; 15 : 628 – 36 . 
 Juneja  M ,  Jain  R ,  Singh  V ,  Mallika  V .  Iron defi ciency in Indian 24. 
children with attention defi cit hyperactivity disorder .  Indian Pediat-
rics  2010 ; 47 : 955 – 8 . 
 Arnold  LE ,  DiSilvestro  RA .  Zinc in attention-defi cit/hyperactivity 25. 
disorder .  J Child Adolesc Psychopharmacol  2005 ; 15 : 619 – 27 . 
 Cortese  S ,  Lecendreux  M ,  Bernardina  BD ,  Mouren  MC ,  Sbarbati  A , 26. 
 Konofal  E .  Attention-defi cit/hyperactivity disorder, Tourette ’ s 
syndrome, and restless legs syndrome: The iron hypothesis .  Med 
Hypotheses  2008 ; 70 : 1128 – 32 . 
 Smuts  CM ,  Tichelaar  HY ,  van Jaarsveld  PJ ,  Badenhorst  CJ ,  27. 
Kruger  M ,  Laubscher  R ,  et  al .  The effect of iron fortifi cation on 
the fatty acid composition of plasma and erythrocyte membranes 
in primary school children with and without iron defi ciency .  
Prostaglandins Leukot Essent Fatty Acids  1995 ; 52 : 59 – 67 . 
 Nigg  JT ,  Lewis  K ,  Edinger  T ,  Falk  M .  Meta-analysis of attention-28. 
defi cit/hyperactivity disorder or attention-defi cit/hyperactivity 
disorder symptoms, restriction diet, and synthetic food color 
additives .  J Am Acad Child Adolesc Psychiatry  2012 ; 51 : 
86 – 97.e8 . 
 Sonuga-Barke  EJS ,  Brandeis  D ,  Cortese  S ,  Daley  D ,  Ferrin  M , 29. 
 Holtmann  M ,  et  al .  Nonpharmacological interventions for ADHD: 
Systematic review and meta-analyses of randomized controlled 
trials of dietary and psychological treatments .  Am J Psychiatry 
 2013 ; 170 : 275 – 89 . 
ineffi cient in some children with ADHD and may have 
problematic side-effects. It therefore seems worthwhile to 
continue research on diet, specifi cally to examine the 
long-term effect of restricted diets in sensitive children 
and to perform a suffi ciently powered long-term trial 
with an appropriate dose of fi sh oil. 
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